Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 5Other solid neoplasm 5Breast 3Gastrointestinal 2Other hematologic neoplasm 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Spondylitis, Ankylosing 1Psoriasis 1Melanoma 1Lupus Erythematosus, Systemic 1Inflammatory Bowel Diseases 1Crohn Disease 1Colitis, Ulcerative 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthritis, Reactive 1Arthritis, Psoriatic 1

Interventions

Nivolumab 24pembrolizumab 23Ipilimumab 17Specimen Handling 16Magnetic Resonance Spectroscopy 10CTLA-4 Antigen 8Opdualag 7relatlimab 6Cyclophosphamide 6binimetinib 5Paclitaxel 5Biopsy 5trametinib 4fludarabine phosphate 4fludarabine 4cemiplimab 4Carboplatin 4lifileucel 3dabrafenib 3atezolizumab 3X-Rays 3Taxes 3Standard of Care 3Radiotherapy 3Radiation 3Pemetrexed 3Introns 3Interferon alpha-2 3Immunoglobulin G 3Gemcitabine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interviews as Topic × Dermatologic × 30 days × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡